Cited by 549Tryptophan and brain disordersNeurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.

The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin Transporters

Zhu, Chong-Bin, Blakely, Randy D, Hewlett, William A·2006·Neuropsychopharmacology

Open this paper in CoChat — free account

Abstract

Proinflammatory cytokines and serotonergic homeostasis have both been implicated in the pathophysiology of major psychiatric disorders. We have demonstrated that activation of p38 mitogen-activated protein kinase (MAPK) induces a catalytic activation of the serotonin transporter (SERT) arising from a reduction in the SERT Km for 5-hydroxytryptamine (5-HT). As inflammatory cytokines can activate p38 MAPK, we hypothesized that they might also activate neuronal SERT. Indeed, Interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha) stimulated serotonin uptake in both the rat embryonic raphe cell line, RN46A, and in mouse midbrain and striatal synaptosomes. In RN46A cells, IL-1beta stimulated 5-HT uptake in a dose- and time-dependent manner, peaking in 20 min at 100 ng/ml. This was abolished by IL-1ra (20 ng/ml), an antagonist of the IL-1 receptor, and by SB203580 (5 microM), a p38 MAPK inhibitor. TNF-alpha also dose- and time-dependently stimulated 5-HT uptake that was only partially blocked by SB203580. Western blots showed that IL-1beta and TNF-alpha activated p38 MAPK, in an SB203580-sensitive manner. IL-1beta induced an SB203580-sensitive decrease in 5-HT Km with no significant change in Vmax. In contrast, TNF-alpha stimulation decreased 5-HT Km and increased SERT Vmax. SB203580 selectively blocked the TNF-alpha-induced change in SERT Km. In mouse midbrain and striatal synaptosomes, maximal stimulatory effects on 5-HT uptake occurred at lower concentrations (IL-1beta, 10 ng/ml; TNF-alpha, 20 ng/ml), and over shorter incubation times (10 min). As with RN46A cells, the effects of IL-1beta and TNF-alpha were completely (IL-1beta) or partially (TNF-alpha) blocked by SB203580. These results provide the first evidence that proinflammatory cytokines can acutely regulate neuronal SERT activity via p38 MAPK-linked pathways.

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1301029

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985 · cited 1×
“Similarly, short-term exposure of hippocampal neurons to TNF-a (15–30 min) has been found to induce endocytosis of GABA-A receptors and increase trafficking of excitatory AMPA receptors to the plasma membrane (Stellwagen et al, 2005).”
Background
cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin Superfamily
Sims, J. E., March, C. J., Cosman, D. J., Widmer, M. B., MacDonald, H. R., McMahan, C. J., Grubin, C. E., Wignall, J. M., Jackson, J. L., Call, S. M., et al. (1988) · Science · doi:10.1126/science.2969618 · Cited by 877
Cytokine‐Induced Sickness Behavior: Mechanisms and Implications
Dantzer, R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05827.x · Cited by 825
Psychopharmacology: The Fourth Generation of Progress
Kramlinger, K. G. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.10.1021-a · Cited by 779
Interleukin-1 Immunoreactive Innervation of the Human Hypothalamus
Breder, C. D., Dinarello, C. A., & Saper, C. B. (1988) · Science · doi:10.1126/science.3258444 · Cited by 755
Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.
Brockhaus, M., Schönfeld, H., Schlaeǵer, E.-J., Hunziker, W. H., Lesslauer, W., & Loetscher, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3127 · Cited by 649
TNF‐α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle
Li, Y.-P., Chen, Y., John, J., Moylan, J. S., Jin, B., Mann, D. L., & Reid, M. B. (2005) · The FASEB Journal · doi:10.1096/fj.04-2364com · Cited by 634

Flagged first, then by citations

Show all 63 references

1 of the 63 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 547

Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium
Horikawa, H., Kato, T. A., Mizoguchi, Y., Monji, A., Seki, Y., Ohkuri, T., Gotoh, L., Yonaha, M., Ueda, T., Hashioka, S., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.015 · Cited by 118
The TNF-α System: Functional Aspects in Depression, Narcolepsy and Psychopharmacology
Berthold-Losleben, M., & Himmerich, H. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777238 · Cited by 119
Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments
Rieder, E. A., & Tausk, F. (2011) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2011.05071.x · Cited by 117
Antidepressant-Like Effect and Mechanism of Action of Honokiol on the Mouse Lipopolysaccharide (LPS) Depression Model
Zhang, B., Wang, P., Hu, K., Li, L., Yu, X. L., Lu, Y., & Hong-sheng, C. (2019) · Molecules · doi:10.3390/molecules24112035 · Cited by 116
Regulatory T cells increased while IL-1β decreased during antidepressant therapy
Himmerich, H., Milenović, S., Fulda, S., Plümäkers, B., Sheldrick, A. J., Michel, T. M., Kircher, T., & Rink, L. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.03.005 · Cited by 116
Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression
Maes, M., Ringel, K., Kubera, M., Berk, M., & Rybakowski, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.11.016 · Cited by 116
Ontogeny and regulation of the serotonin transporter: Providing insights into human disorders
Daws, L. C., & Gould, G. G. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.013 · Cited by 121
Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation
Hoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 120
TNFα and IL-1β but not IL-18 Suppresses Hippocampal Long-Term Potentiation Directly at the Synapse
Prieto, G. A., Tong, L., Smith, E. D., & Cotman, C. W. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2517-8 · Cited by 121
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
Principles of inflammasome priming and inhibition: implications for psychiatric disorders
Herman, F. J., & Pasinetti, G. M. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.010 · Cited by 115
Abnormal protein and mRNA expression of inflammatory cytokines in the prefrontal cortex of depressed individuals who died by suicide
Pandey, G. N., Rizavi, H. S., Zhang, H., Bhaumik, R., & Ren, X. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170192 · Cited by 113
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System
Rossi, S., Sacchetti, L., Napolitano, F., Chiara, V. D., Motta, C., Studer, V., Musella, A., Barbieri, F. R., Bari, M., Bernardi, G., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1515-12.2012 · Cited by 118
Repeated Lipopolysaccharide (LPS) or Cytokine Treatments Sensitize Ethanol Withdrawal-Induced Anxiety-Like Behavior
Breese, G. R., Knapp, D. J., Overstreet, D. H., Navarro, M., Wills, T. A., & Angel, R. A. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301468 · Cited by 110
Diverse effects of gut-derived serotonin in intestinal inflammation
Shajib, M. S., Baranov, A., & Khan, W. I. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00414 · Cited by 109
STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior
Kong, E., Sučić, S., Monje, F. J., Reisinger, S. N., Savalli, G., Diao, W., Khan, D., Ronovsky, M., Cabatic, M., Koban, F., et al. (2015) · Scientific Reports · doi:10.1038/srep09009 · Cited by 114
Anti-TNF-α Compounds as a Treatment for Depression
Uzzan, S., & Azab, A. N. (2021) · Molecules · doi:10.3390/molecules26082368 · Cited by 112
Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: Implications for oligodendrocyte viability
Carter, C. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2006.11.009 · Cited by 106
Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy
An, K., Hao, H., Zheng, X., Liang, Y. L., Xie, Y., Xie, T., Dai, C., Zhao, Q., Wu, X., Xie, L. Y., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-100 · Cited by 106
Antidepressant effects of TNF-α blockade in an animal model of depression
Krügel, U., Fischer, J., Radicke, S., Sack, U., & Himmerich, H. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.01.007 · Cited by 104
Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation
Hughes, M. M., Carballedo, A., McLoughlin, D. M., Amico, F., Harkin, A., Frodl, T., & Connor, T. J. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.010 · Cited by 107
(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors
Maes, M. H. J., Leonard, B. E., Fernandez, A., Kubera, M., Nowak, G., Veerhuis, R., Gardner, A., Ruckoanich, P., Geffard, M., Altamura, C. A., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.019 · Cited by 103
Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application
Watkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53
Rossi, S., Motta, C., Studer, V., Macchiarulo, G., Volpe, E., Barbieri, F. R., Ruocco, G., Buttari, F., Finardi, A., Mancino, R., et al. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-56 · Cited by 102
Serotonin paracrine signaling in tissue fibrosis
Mann, D. A., & Oakley, F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.009 · Cited by 98
Role of brain transmigrating neutrophils in depression-like behavior during systemic infection
Aguliar-Valles, A., Kim, J., Jung, S., Woodside, B., & Luheshi, G. N. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.137 · Cited by 97
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters
Bermingham, D. P., & Blakely, R. D. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012260 · Cited by 97
Self-citation
Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery
Robson, M. J., Quinlan, M. A., & Blakely, R. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00412 · Cited by 96
Self-citation
Targeting neuroinflammation by polyphenols: A promising therapeutic approach against inflammation-associated depression
Tayab, M. A., Islam, M. N., Chowdhury, K. A. A., & Tasnim, F. M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112668 · Cited by 100
Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms
Vancassel, S., Capuron, L., & Castanon, N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00499 · Cited by 102
Etiological mechanisms of post-stroke depression: a review
Fang, J., & Cheng, Q. H. (2009) · Neurological Research · doi:10.1179/174313209x385752 · Cited by 96
Role of Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways in the Etiology of Depression: Therapeutic Implications
Anderson, G., Berk, M., Dean, O. M., Moylan, S., & Maes, M. H. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0119-1 · Cited by 95
The pathogenesis of cancer related fatigue: Could increased activity of pro-inflammatory cytokines be the common denominator?
Jager, A., Sleijfer, S., & van der Rijt, C. C. D. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.11.023 · Cited by 96
IFN-γ and TNF-α decrease serotonin transporter function and expression in Caco2 cells
Foley, K. F., Pantano, C., Ciolino, A. L., & Mawe, G. M. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00470.2006 · Cited by 94
Central nervous system inflammation in disease related conditions: Mechanistic prospects
Fung, A., Vizcaychipi, M. P., Lloyd, D. G., Wan, Y., & Ma, D. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.061 · Cited by 95
Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus
Postal, M., Lapa, A. T., Sinicato, N. A., Peliçari, K. D. O., Peres, F. A., Costallat, L. T. L., Fernandes, P. T., Marini, R., & Appenzeller, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0471-9 · Cited by 98
Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms
Heitmann, H., Andlauer, T., Korn, T., Mühlau, M., Henningsen, P., Hemmer, B., & Ploner, M. (2020) · Multiple Sclerosis · doi:10.1177/1352458520972279 · Cited by 87
Inflammation modulates anxiety in an animal model of multiple sclerosis
Peruga, I., Hartwig, S., Thöne, J., Hovemann, B. T., Gold, R., Juckel, G., & Linker, R. A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.018 · Cited by 93
Brain-Derived Neurotrophic Factor Serum Levels and Genotype: Association with Depression during Interferon-α Treatment
Lotrich, F. E., Albusaysi, S., & Ferrell, R. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.263 · Cited by 92
Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression
Ranjbar, E., Shams, J., Sabetkasaei, M., M-Shirazi, M., Rashidkhani, B., Mostafavi, A., Bornak, E., & Nasrollahzadeh, J. (2014) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000066 · Cited by 92
Effects of Centrally Administered Etanercept on Behavior, Microglia, and Astrocytes in Mice Following a Peripheral Immune Challenge
Camara, M. L., Corrigan, F., Jaehne, E. J., Jawahar, M. C., Anscomb, H., & Baune, B. T. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.199 · Cited by 92
A review on inflammatory cytokine-induced alterations of the brain as potential neural biomarkers in post-traumatic stress disorder
Kim, Y., Amidfar, M., & Won, E. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.008 · Cited by 96
Senegenin exerts anti-depression effect in mice induced by chronic un-predictable mild stress via inhibition of NF-κB regulating NLRP3 signal pathway
Li, H., Lin, S., Qin, T., Li, H., Ma, Z., & Ma, S. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.10.001 · Cited by 91
Role of Inflammation in Depression and Treatment Implications
Felger, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_166 · Cited by 94
Where in the serotonergic system does it go wrong? Unravelling the route by which the serotonergic system affects feather pecking in chickens
Haas, E. N. D., & van der Eijk, J. A. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.007 · Cited by 97
T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model
Slyepchenko, A., Maes, M., Köhler, C. A., Anderson, G., Quevedo, J., Alves, G. S., Berk, M., Fernandes, B. S., & Carvalho, A. F. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.002 · Cited by 89
Role of Inflammation in Depression: Implications for Phenomenology, Pathophysiology and Treatment
Raison, C. L., & Miller, A. H. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343966 · Cited by 88
Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets
Misiak, B., Beszłej, J. A., Kotowicz, K., Szewczuk-Bogusławska, M., Samochowiec, J., Kucharska–Mazur, J., & Frydecka, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.021 · Cited by 87
Depression as an evolutionary strategy for defense against infection
Anders, S. L., Tanaka, M., & Kinney, D. K. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.12.002 · Cited by 87
Stress-Related Immune Markers in Depression: Implications for Treatment
Hughes, M. M., Connor, T. J., & Harkin, A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw001 · Cited by 91
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
Smith, A. K., Simon, J. S., Gustafson, E. L., Noviello, S., Cubells, J. F., Epstein, M. P., Devlin, D. J., Qiu, P., Albrecht, J. K., Brass, C. A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.67 · Cited by 84
Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities
Réus, G. Z., Manosso, L. M., Quevedo, J., & Carvalho, A. F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105425 · Cited by 94
AUGMENTATION OF FLUOXETINE WITH LOVASTATIN FOR TREATING MAJOR DEPRESSIVE DISORDER, A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED-CLINICAL TRIAL: Lovastatin for Treating Depression
Ghanizadeh, A., & Hedayati, A. (2013) · Depression and Anxiety · doi:10.1002/da.22195 · Cited by 81
The Neurobiological Pathogenesis of Poststroke Depression
Feng, C., Fang, M., & Liu, X. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/521349 · Cited by 82
Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro
Su, F., Yi, H., Xu, L., & Zhang, Z. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.028 · Cited by 82
Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants
Martín-Hernández, D., Caso, J. R., Javier Meana, J., Callado, L. F., Madrigal, J. L. M., García-Bueno, B., & Leza, J. C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1294-2 · Cited by 80
Seahorse treatment improves depression-like behavior in mice exposed to CUMS through reducing inflammation/oxidants and restoring neurotransmitter and neurotrophin function
Li, K., Yan, L., Zhang, Y., Yang, Z., Zhang, C., Li, Y., Kalueff, A. V., Li, W., & Song, C. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112487 · Cited by 80
Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in depression: A meta-analysis
Su, M., Ouyang, X., & Song, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.038 · Cited by 80
Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review
Woo, Y., Seo, H.-J., McIntyre, R., & Bahk, W.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010080 · Cited by 79
Single Molecule Analysis of Serotonin Transporter Regulation Using Antagonist-Conjugated Quantum Dots Reveals Restricted, p38 MAPK-Dependent Mobilization Underlying Uptake Activation
Chang, J. C., Tomlinson, I. D., Warnement, M. R., Ustione, A., Carneiro, A. M. D., Piston, D. W., Blakely, R., & Rosenthal, S. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0048-12.2012 · Cited by 78
Self-citation
Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs
Malemud, C. J., & Miller, A. H. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.2.171 · Cited by 78
Effects of perillaldehyde on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration
Ji, W., Wang, S., Ma, Z., Li, R., Li, S., Xue, J., Li, W. S., Niu, X.-X., Lü, Y., Zhang, X., et al. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.10.026 · Cited by 80
Depression following a traumatic brain injury: uncovering cytokine dysregulation as a pathogenic mechanism
Bachstetter, A. D., Bodnar, C., & Morganti, J. M. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238604 · Cited by 85
How Oxidative Stress Induces Depression?
Ji, N., Lei, M., Chen, Y., Tian, S., Li, C., & Zhang, B. (2023) · ASN NEURO · doi:10.1177/17590914231181037 · Cited by 84
Treatment-resistant depression: molecular mechanisms and management
Kajumba, M. M., Kakooza‐Mwesige, A., Nakasujja, N., Attix, D. K., & Canli, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00205-y · Cited by 93
Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response
Powell, T. R., Schalkwyk, L. C., Heffernan, A. L., Breen, G. D., Lawrence, T., Price, T., FARMER, A. E., Aitchison, K. J., Craig, I., Danese, A., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.009 · Cited by 75
Anti-inflammatory cytokines in autism spectrum disorders: A systematic review and meta-analysis
Saghazadeh, A., Ataeinia, B., Keynejad, K., Abdolalizadeh, A., Hirbod‐Mobarakeh, A., & Rezaei, N. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154740 · Cited by 82
Parasite-induced alterations of sensorimotor pathways in gammarids: collateral damage of neuroinflammation?
Helluy, S. (2012) · Journal of Experimental Biology · doi:10.1242/jeb.073213 · Cited by 72
Old Friends, immunoregulation, and stress resilience
Langgartner, D., Lowry, C. A., & Reber, S. O. (2018) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2228-7 · Cited by 76
Food allergy and food‐based therapies in neurodevelopmental disorders
de Theije, C. G. M., Bavelaar, B. M., da Silva, S. L., Korte, S. M., Olivier, B., Garssen, J., & Kraneveld, A. D. (2013) · Pediatric Allergy and Immunology · doi:10.1111/pai.12149 · Cited by 71
How environmental enrichment balances out neuroinflammation in chronic pain and comorbid depression and anxiety disorders
Kimura, L. F., Novaes, L. S., Picolo, G., Munhoz, C. D., Cheung, C. W., & Camarini, R. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15584 · Cited by 74
Targeting inflammation to influence mood following spinal cord injury: a randomized clinical trial
Allison, D. J., & Ditor, D. S. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0425-2 · Cited by 72
Pathogenesis ofTaenia soliumtaeniasis and cysticercosis
Gonzáles, I., Rivera, J., Garcia, H. H., & for The Cysticercosis Working Group in Peru (2016) · Parasite Immunology · doi:10.1111/pim.12307 · Cited by 71
5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress
Xu, L., Wu, Y., Yan, F., Li, C., Dai, Z., You, Q., Jiang, Z., & Di, B. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.003 · Cited by 70
Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms
Korte, S. M., & Straub, R. H. (2019) · Rheumatology · doi:10.1093/rheumatology/kez413 · Cited by 71
Animal inflammation-based models of depression and their application to drug discovery
Ma, L., Demin, K. A., Kolesnikova, T. O., Kharsko, S. L., Zhu, X., Yuan, X., Song, C., Мешалкина, Д. А., Leonard, B. E., Tian, L., et al. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1362385 · Cited by 71
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
Köhler‐Forsberg, K., Jorgensen, A., Dam, V. H., Stenbæk, D. S., Fisher, P. M., Ip, C.-T., Ganz, M., Poulsen, H. E., Giraldi, A. G. E., Ozenne, B., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00641 · Cited by 67
Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice
van Heesch, F., Prins, J., Korte-Bouws, G. A. H., Westphal, K. G. C., Lemstra, S., Olivier, B., Kraneveld, A. D., & Korte, S. M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.038 · Cited by 59
The Brain–Skin Connection and the Pathogenesis of Psoriasis: A Review with a Focus on the Serotonergic System
Martins, A. M., Ascenso, A., Ribeiro, H. M., & Marto, J. M. (2020) · Cells · doi:10.3390/cells9040796 · Cited by 66
Inflammation-Induced Histamine Impairs the Capacity of Escitalopram to Increase Hippocampal Extracellular Serotonin
Hersey, M., Samaranayake, S., Berger, S. N., Tavakoli, N. S., Mena, S., Nijhout, H. F., Reed, M. C., Best, J. A., Blakely, R., Reagan, L. P., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2618-20.2021 · Cited by 57
Self-citation
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis
Gentile, A., Fresegna, D., Federici, M., Musella, A., Rizzo, F. R., Sepman, H., Bullitta, S., Vito, F. D., Haji, N., Rossi, S., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.11.022 · Cited by 59
Cancer-related fatigue in the elderly
Giacalone, A., Quitadamo, D., Zanet, E., Berretta, M., Spina, M., & Tirelli, U. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1897-1 · Cited by 62
Rapid Stimulation of Presynaptic Serotonin Transport by A3 Adenosine Receptors
Zhu, C.-B., Steiner, J. A., Munn, J. L., Daws, L. C., Hewlett, W. A., & Blakely, R. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121665 · Cited by 58
Self-citation
Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats
Bayramgürler, D., Karson, A., Özer, C., & Utkan, T. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.06.010 · Cited by 62
Cytokine gene variation is associated with depressive symptom trajectories in oncology patients and family caregivers
Dunn, L. B., Aouizerat, B. E., Langford, D. J., Cooper, B. A., Dhruva, A., Cataldo, J. K., Baggott, C., Merriman, J. D., Dodd, M. J., West, C. M., et al. (2012) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2012.10.004 · Cited by 58
Glucocorticoids and Inflammation: A Double-Headed Sword in Depression?
Horowitz, M. A., Zunszain, P. A., Anacker, C., Musaelyan, K., & Pariante, C. M. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343980 · Cited by 57
Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humans
Krishnadas, R., Nicol, A., Sassarini, J., Puri, N., Burden, A. D., Leman, J. A., Combet, E., Pimlott, S. L., Hadley, D. M., McInnes, I. B., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.08.005 · Cited by 61
p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse
Robson, M. J., Quinlan, M. A., Margolis, K. G., Gajewski-Kurdziel, P. A., Veenstra-VanderWeele, J. M., Gershon, M. D., Watterson, D. M., & Blakely, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809137115 · Cited by 58
Self-citation
Intricate role of sleep deprivation in modulating depression: focusing on BDNF, VEGF, serotonin, cortisol, and TNF-α
Vaseghi, S., Mostafavijabbari, A., Alizadeh, M.-S., Ghaffarzadegan, R., Kholghi, G., & Zarrindast, M. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01124-z · Cited by 59
Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-κB, p38 and JNK
Daniele, S., Pozzo, E. D., Zappelli, E., & Martini, C. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.006 · Cited by 57
Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease
More, S. V., & Choi, D. (2017) · Nutrients · doi:10.3390/nu9050451 · Cited by 56
Multifaceted Regulations of the Serotonin Transporter: Impact on Antidepressant Response
Baudry, A., Pietri, M., Launay, J., Kellermann, O., & Schneider, B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00091 · Cited by 59
5‐HT1B autoreceptor regulation of serotonin transporter activity in synaptosomes
Hagan, C. E., McDevitt, R. A., Liu, Y. K., Furay, A. R., & Neumaier, J. F. (2012) · Synapse · doi:10.1002/syn.21608 · Cited by 55
MDDScore
Bilello, J. A., Thurmond, L. M., Smith, K., Pi, B., Rubín, R. T., Wright, S., Taub, F. E., Henry, M., Shelton, R. C., & Papakostas, G. I. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09029 · Cited by 56
The genetics of selective serotonin reuptake inhibitors
Kroeze, Y., Zhou, H., & Homberg, J. R. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.015 · Cited by 55
The many different faces of major depression: It is time for personalized medicine
Korte, S. M., Prins, J., Krajnc, A. M., Hendriksen, H., Oosting, R. S., Westphal, K. G. C., Korte-Bouws, G. A. H., & Olivier, B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.045 · Cited by 54
Hashimoto’s thyroiditis induces neuroinflammation and emotional alterations in euthyroid mice
Cai, Y., Wang, F., Chen, Z.-X., Li, L., Fan, H., Wu, Z., Ge, J., Hu, W., Wang, Q., & Zhu, D.-F. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1341-z · Cited by 56
Microglial activation and neurobiological alterations in experimental autoimmune prostatitis-induced depressive-like behavior in mice
Du, H., Chen, X., Zhang, L., Liu, Y., Zhan, C., Chen, J., Zhang, Y., Yu, Z., Zhang, J., Yang, H., et al. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s211288 · Cited by 52
Co-Morbidity between Cardiovascular Pathology and Depression: Role of Inflammation
Halaris, A. E. (2013) · Modern trends in psychiatry · doi:10.1159/000343981 · Cited by 53
Emerging Roles of Gut Serotonin in Regulation of Immune Response, Microbiota Composition and Intestinal Inflammation
Grondin, J. A., & Khan, W. I. (2023) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwad020 · Cited by 51

Authors: Zhu, C.-B., Blakely, R. D., & Hewlett, W. A.
Affiliations: Vanderbilt University (US)
Corresponding author: Hewlett, William A
ORCID: Zhu, Chong-Bin
Blakely, Randy D
Venue: Neuropsychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2006-02-01
Volume: 31
Issue: 10
Pages: 2121-2131
ISSN: 0893-133X (ISSN-L)
1740-634X
DOI: 10.1038/sj.npp.1301029
OpenAlex: W2065313926
Cited by: 549
References: 63
Citations by year: 2026: 14 · 2025: 19 · 2024: 21 · 2023: 32 · 2022: 32 · 2021: 34 · 2020: 30 · 2019: 31 · 2018: 28 · 2017: 21 · 2016: 33 · 2015: 38 · 2014: 38 · 2013: 40 · 2012: 37
FWCI: 5.81
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Neuropsychopharmacology (publishedVersion)
PubMed (publishedVersion)
Funders: National Alliance for Research on Schizophrenia and Depression
National Institute on Drug Abuse (DA-07390, R01DA007390)
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords: serotonin transporter, IL-1β, TNF-α, inflammatory cytokines, p38 MAPK, serotonin uptake, serotonin, neuroinflammation, interleukin-1 receptor antagonist, SB203580, synaptosomes, midbrain, striatum
MeSH terms: Analysis of Variance, Animals, Cell Line, Corpus Striatum, Dose-Response Relationship, Drug, Drug Interactions, Enzyme Activation, Enzyme Inhibitors, Interleukin-1, Mesencephalon, Neurons, Raphe Nuclei, Serotonin, Synaptosomes, Tumor Necrosis Factor-alpha, p38 Mitogen-Activated Protein Kinases, Serotonin Plasma Membrane Transport Proteins, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin Transporters

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks